http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102134210-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4711b7defc1422cdb7f86d2c95657bf
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C319-20
filingDate 2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fac2691859523b797ad3422aa985bc77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_128ebf3696b16017036e5e0b9c0d2180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac5c8bfbf120c217f8f45b5efb8d655
publicationDate 2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102134210-B
titleOfInvention Leonurine derivative and preparation method thereof
abstract The invention belongs to the field of medicament synthesis, in particular relating to a derivative obtained by combining leonurine with an L-cysteine analogue and a synthesis method thereof. The preparation method comprises the following steps: on the basis of utilizing syringic acid as a starting raw material, successively carrying out carbonylation reaction, esterification reaction, ester hydrolysis reaction and the like, so as to synthesize the derivative obtained by combining the leonurine with the L-cysteine analogue. The method is strong in operability and easy to control, the reaction condition is simple, the yield and purity of the product are high, the derivative obtained by combining the leonurine with the L-cysteine analogue can be used as a novel candidate medicament released by endogenous hydrothion.
priorityDate 2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008031322-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009015561-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22381085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425755001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416219654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID225680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10742
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6367
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415885211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148244282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423021672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413304947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57496573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410498166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468055082

Total number of triples: 43.